FOLH1 and prostate carcinoma: A meta-analysis included 298 patients with prostate cancer who underwent traditional imaging studies and PSMA PET-CT, the detection of metastatic LNs was higher by PSMA PET-CT than with CT and MRI (71% sensitivity and 95% specificity) [45].